| Diabetic cardiomyopathy revisited S Boudina, ED Abel Circulation 115 (25), 3213-3223, 2007 | 2040 | 2007 |
| Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver ED Abel, O Peroni, JK Kim, YB Kim, O Boss, E Hadro, T Minnemann, ... Nature 409 (6821), 729-733, 2001 | 1663 | 2001 |
| Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T cell responses PC Ho, JD Bihuniak, AN Macintyre, M Staron, X Liu, R Amezquita, ... Cell 162 (6), 1217-1228, 2015 | 1370 | 2015 |
| PGC-1α deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis TC Leone, JJ Lehman, BN Finck, PJ Schaeffer, AR Wende, S Boudina, ... PLoS biology 3 (4), e101, 2005 | 1235 | 2005 |
| Cardiac metabolism in heart failure: implications beyond ATP production T Doenst, TD Nguyen, ED Abel Circulation research 113 (6), 709-724, 2013 | 1211 | 2013 |
| The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function AN Macintyre, VA Gerriets, AG Nichols, RD Michalek, MC Rudolph, ... Cell metabolism 20 (1), 61-72, 2014 | 1181 | 2014 |
| Molecular mechanisms of diabetic cardiomyopathy H Bugger, ED Abel Diabetologia 57, 660-671, 2014 | 1107 | 2014 |
| Diabetic cardiomyopathy, causes and effects S Boudina, ED Abel Reviews in Endocrine and Metabolic Disorders 11, 31-39, 2010 | 1008 | 2010 |
| Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance A Zisman, OD Peroni, ED Abel, MD Michael, F Mauvais-Jarvis, BB Lowell, ... Nature medicine 6 (8), 924-928, 2000 | 996 | 2000 |
| Cardiac remodeling in obesity ED Abel, SE Litwin, G Sweeney Physiological reviews 88 (2), 389-419, 2008 | 944 | 2008 |
| Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity S Boudina, S Sena, BT O’Neill, P Tathireddy, ME Young, ED Abel Circulation 112 (17), 2686-2695, 2005 | 897* | 2005 |
| Cardiac energy metabolism in heart failure GD Lopaschuk, QG Karwi, R Tian, AR Wende, ED Abel Circulation research 128 (10), 1487-1513, 2021 | 805 | 2021 |
| Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins S Boudina, S Sena, H Theobald, X Sheng, JJ Wright, XX Hu, S Aziz, ... Diabetes 56 (10), 2457-2466, 2007 | 714 | 2007 |
| Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity J Buchanan, PK Mazumder, P Hu, G Chakrabarti, MW Roberts, UJ Yun, ... Endocrinology 146 (12), 5341-5349, 2005 | 709 | 2005 |
| Nicotinamide riboside is uniquely and orally bioavailable in mice and humans SAJ Trammell, MS Schmidt, BJ Weidemann, P Redpath, F Jaksch, ... Nature communications 7 (1), 12948, 2016 | 702 | 2016 |
| Heart failure in type 2 diabetes mellitus: impact of glucose-lowering agents, heart failure therapies, and novel therapeutic strategies HC Kenny, ED Abel Circulation research 124 (1), 121-141, 2019 | 680 | 2019 |
| GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration EA Winkler, Y Nishida, AP Sagare, SV Rege, RD Bell, D Perlmutter, ... Nature neuroscience 18 (4), 521-530, 2015 | 658 | 2015 |
| Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts PK Mazumder, BT O’Neill, MW Roberts, J Buchanan, UJ Yun, ... Diabetes 53 (9), 2366-2374, 2004 | 557 | 2004 |
| Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells A Caro-Maldonado, R Wang, AG Nichols, M Kuraoka, S Milasta, LD Sun, ... The Journal of Immunology 192 (8), 3626-3636, 2014 | 548 | 2014 |
| Basic mechanisms of diabetic heart disease RH Ritchie, ED Abel Circulation research 126 (11), 1501-1525, 2020 | 511 | 2020 |
